Education
About Us
Working with TipRanks
Follow Us
Agilon Health Inc (AGL)
NYSE:AGL
AGL Stock Chart & Stats
$0.76
$0.02(1.16%)
At close: 4:00 PM EST
$0.76
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$0.51 - $6.08
Previous CloseN/A
Volume1.09M
Average Volume (3M)5.29M
Market Cap
$285.77M
Enterprise Value$127.20M
Total Cash (Recent Filing)$310.85M
Total Debt (Recent Filing)$37.12M
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Feb 25, 2026EPS Estimate
-0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding414,581,600
10 Day Avg. Volume6,028,691
30 Day Avg. Volume5,290,405
Financial Highlights & Ratios
PEG Ratio1.92
Price to Book (P/B)1.66
Price to Sales (P/S)0.13
P/FCF Ratio-10.99
Enterprise Value/Market Cap0.45
Enterprise Value/Revenue0.02
Enterprise Value/Gross Profit-1.11
Enterprise Value/Ebitda-0.44
Forecast
1Y Price Target
$1.19Price Target Upside56.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost Reductions And Contract DisciplineSecured operating cost reductions of about thirty million for 2026, paired with more disciplined payer contracting and lower Part D exposure, supports margin recovery and a clearer path to improved EBITDA.
Data And Reporting VisibilityEnhanced data aggregation and reporting platform covering about eighty percent of members gives management better visibility into claims and payer activity, which should reduce earnings volatility.
Medicare Advantage Rate IncreasesAnalyst notes a five percent Medicare Advantage rate increase for 2026 and a higher CMS benchmark that could boost premium revenue and improve plan margins.
Bears Say
Earnings Shortfall And Weakened GuidanceSignificantly lower adjusted EBITDA versus consensus and reinstated guidance well below prior expectations have weakened the company's capital cushion and triggered investor sell-off.
High Medical Loss Ratio And Claims CostAn elevated medical loss ratio and persistent high claims costs, including losses in exited markets, increase the likelihood of continued margin pressure and limited earnings visibility.
Regulatory Program Changes And Growth OutlookNarrower ACO REACH risk corridors and an opaque 2026 outlook create headwinds that could keep growth muted as the company focuses on preserving capital.
Agilon Health News
AGL FAQ
What was Agilon Health Inc’s price range in the past 12 months?
Agilon Health Inc lowest stock price was $0.51 and its highest was $6.08 in the past 12 months.
What is Agilon Health Inc’s market cap?
Agilon Health Inc’s market cap is $285.77M.
When is Agilon Health Inc’s upcoming earnings report date?
Agilon Health Inc’s upcoming earnings report date is Feb 25, 2026 which is in 19 days.
How were Agilon Health Inc’s earnings last quarter?
Agilon Health Inc released its earnings results on Nov 04, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.149 by -$0.121.
Is Agilon Health Inc overvalued?
According to Wall Street analysts Agilon Health Inc’s price is currently Undervalued.
Does Agilon Health Inc pay dividends?
Agilon Health Inc pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health Inc dividends here
What is Agilon Health Inc’s EPS estimate?
Agilon Health Inc’s EPS estimate is -0.27.
How many shares outstanding does Agilon Health Inc have?
Agilon Health Inc has 414,581,600 shares outstanding.
What happened to Agilon Health Inc’s price movement after its last earnings report?
Agilon Health Inc reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.149. Following the earnings report the stock price went up 4.006%.
Which hedge fund is a major shareholder of Agilon Health Inc?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.19 (56.58% Upside)
$1.19 (56.58% Upside)
Blogger Sentiment
Bullish
AGL Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 212.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $50.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.2%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.20%
12-Months-Change
Fundamentals
Return on Equity
-73.31%
Trailing 12-Months
Asset Growth
-23.68%
Trailing 12-Months
Company Description
Agilon Health Inc
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
AGL Company Deck
AGL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of both positive and negative aspects. While agilon Health highlighted operational improvements, cost reductions, and successful clinical programs, significant financial challenges such as negative margins, declining membership, and lower-than-expected risk adjustments were also evident.View all AGL earnings summariesAGL Stock 12 Month Forecast
Average Price Target
$1.19
▲(56.58% Upside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
2.43% Insiders
22.26% Mutual Funds
0.06% Other Institutional Investors
65.13% Public Companies and
Individual Investors